LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.01 | 21.74 | 1169 | 901 | 1.2961 | 1.0989 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.01 | 21.74 | 1 | 901 | 0.0011 | -0.4361 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.01 | 21.74 | 1083 | 901 | 1.2008 | 1.0693 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.01 | 21.74 | 574 | 901 | 0.6364 | 0.8387 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 20.01 | 21.74 | 1100 | 901 | 1.2196 | 1.0753 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.98 | 21.74 | 392 | 1108 | 0.3537 | 0.6651 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.98 | 21.74 | 1218 | 1108 | 1.0989 | 1.0335 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.98 | 21.74 | 5 | 1108 | 0.0045 | -0.2283 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.98 | 21.74 | 1189 | 1108 | 1.0728 | 1.0249 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.98 | 21.74 | 870 | 1108 | 0.7850 | 0.9164 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 21.98 | 21.74 | 1160 | 1108 | 1.0466 | 1.0161 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.95 | 21.74 | 641 | 1354 | 0.4732 | 0.7641 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.95 | 21.74 | 1254 | 1354 | 0.9258 | 0.9743 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.95 | 21.74 | 53 | 1354 | 0.0391 | 0.1612 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.95 | 21.74 | 1249 | 1354 | 0.9221 | 0.9730 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.95 | 21.74 | 1090 | 1354 | 0.8047 | 0.9284 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 23.95 | 21.74 | 1198 | 1354 | 0.8844 | 0.9592 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.92 | 21.74 | 756 | 1515 | 0.4988 | 0.7853 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.92 | 21.74 | 1320 | 1515 | 0.8709 | 0.9554 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.92 | 21.74 | 216 | 1515 | 0.1425 | 0.4550 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.92 | 21.74 | 1329 | 1515 | 0.8769 | 0.9575 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.92 | 21.74 | 1150 | 1515 | 0.7588 | 0.9118 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 25.92 | 21.74 | 1280 | 1515 | 0.8445 | 0.9456 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.89 | 21.74 | 795 | 1677 | 0.4741 | 0.7755 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.89 | 21.74 | 1393 | 1677 | 0.8307 | 0.9417 | MN20160310_N01 | G09 |